25 results
POS AM
EFTR
eFFECTOR Therapeutics Inc
29 Mar 24
Prospectus update (post-effective amendment)
2:51pm
and regulations governing the collection, use, disclosure, retention, and security of personal information. Implementation standards and enforcement practices
PRE 14A
EFTR
eFFECTOR Therapeutics Inc
27 Apr 23
Preliminary proxy
4:06pm
Exculpation Charter Amendment could impact our recruitment and retention of exceptional officer candidates that conclude that the potential exposure
S-3
EX-4.4
EFTR
eFFECTOR Therapeutics Inc
1 Sep 22
Shelf registration
4:02pm
(subject to the record retention requirements of the Exchange Act and the Trustee) and deliver a certificate of such cancellation to the Company upon
8-K/A
EX-10.10
4hevsmz1 uxj
31 Aug 21
Changes in Registrant's Certifying Accountant
4:38pm
8-K/A
EX-10.11
pn0nh5u fwzhq2fr
31 Aug 21
Changes in Registrant's Certifying Accountant
4:38pm
8-K
EX-10.10
uipo4l v58pkpinoz9j
31 Aug 21
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.11
2b4qine
31 Aug 21
Entry into a Material Definitive Agreement
4:10pm
424B3
o3o nfwnk0p3b
10 Aug 21
Prospectus supplement
5:11pm
S-4/A
nzuta 4xw24t7dhxcjeb
19 Jul 21
Registration of securities issued in business combination transactions (amended)
5:21pm
S-4
EX-10.16
fao1x3tpaw
14 Jun 21
Registration of securities issued in business combination transactions
5:10pm
S-4
EX-10.14
wesjxt jgwj
14 Jun 21
Registration of securities issued in business combination transactions
5:10pm
S-4
qzzsbg ib
14 Jun 21
Registration of securities issued in business combination transactions
5:10pm
8-K
EX-10.3
95cvbjx
27 May 21
Gross proceeds expected to include $60 million from a committed PIPE and up to $175 million held in trust
8:27am
8-K
EX-2.1
2qqo7 nctdc
27 May 21
Gross proceeds expected to include $60 million from a committed PIPE and up to $175 million held in trust
8:27am
425
EX-2.1
nx1amcn3547m1 8knt43
27 May 21
Business combination disclosure
8:25am
425
EX-10.3
yarqrcv4 a6f
27 May 21
Business combination disclosure
8:25am
10-K
xnjvm0
29 Mar 21
Annual report
4:18pm